Who Owns BioAge Labs Stock?
NASDAQ: BIOAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 84.91%
- Held by insiders
- 2.36%
- Institutional holders
- 213
- Institutions 84.9%
- Insiders 2.4%
- Public and other 12.7%
Who owns BioAge Labs stock?
Institutional investors own about 84.9% of BioAge Labs's shares, spread across 213 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 2.36% of BIOA.
The largest institutional holders are Blackrock Inc. (7.71%), a16z Capital Management, L.L.C. (7.03%) and Sofinnova Investments, Inc. (4.99%). Together, the top 10 institutions control 42.8% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their BIOA positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of BIOA
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 3.54M | 7.71% | +24.4% |
| a16z Capital Management, L.L.C. | 3.23M | 7.03% | 0.0% |
| Sofinnova Investments, Inc. | 2.29M | 4.99% | 0.0% |
| Cormorant Asset Management, LP | 2.24M | 4.88% | -6.3% |
| MPM Bioimpact LLC | 1.86M | 4.04% | +11.3% |
| Vanguard Capital Management LLC | 1.62M | 3.53% | +5.0% |
| State Street Corporation | 1.35M | 2.93% | +32.0% |
| Octagon Capital Advisors LP | 1.30M | 2.83% | -25.6% |
| Shaw D.E. & Co., Inc. | 1.16M | 2.52% | +55.7% |
| Polar Capital Holdings PLC | 1.07M | 2.33% | -0.3% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of BIOA
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.14M | 2.48% |
| iShares Trust-iShares Russell 2000 ETF | 836.37K | 1.82% |
| SPDR SERIES TRUST-State Street SPDR S&P Pharmaceuticals ETF | 509.87K | 1.11% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 367.98K | 0.80% |
| iShares Trust-iShares Russell 2000 Value ETF | 267.64K | 0.58% |
| iShares Trust-iShares Biotechnology ETF | 246.75K | 0.54% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 225.83K | 0.49% |
| Fidelity Commonwealth Trust II-Fidelity Enhanced Small Cap Core ETF | 204.17K | 0.44% |
| TIAA-CREF Funds-Nuveen Quant Small Cap Equity Fund | 201.86K | 0.44% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 200.86K | 0.44% |
Frequently asked questions
Who is the largest shareholder of BioAge Labs?
Blackrock Inc. is the largest institutional shareholder of BIOA, owning 7.71% of shares outstanding (3.54M shares) as of its latest 13F filing.
What percentage of BioAge Labs is owned by institutions?
Institutions own about 84.9% of BIOA shares and 87.0% of the public float.
How much of BioAge Labs do insiders own?
Insiders, such as officers and directors, own about 2.36% of BIOA shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.